英国人群HER2阳性乳腺癌曲妥珠单抗治疗的社会人口学差异：表2
基于英国人群的HER2阳性乳腺癌患者曲妥珠单抗治疗接受率的逻辑回归结果，涵盖社会人口学差异分析。
基本信息
资源简介
英国人群HER2阳性乳腺癌曲妥珠单抗治疗的社会人口学差异：表2
【一句话概览】
本数据集是 figshare 公开的结构化表格数据集，收录 1 个文件、合计 22.02 KB，主题涵盖 Biological Agents & Therapies、Breast Cancer、Epidemiology、Precision Medicine，可用于统计建模、特征工程与队列分析，CC BY 许可开放获取。
【数据集背景】
本数据集源站标题为《Table 2 from Sociodemographic Disparities in HER2+ Breast Cancer Trastuzumab Receipt: An English Population-Based Study》。配套论文《Sociodemographic Disparities in HER2+ Breast Cancer Trastuzumab Receipt: An English Population-Based Study》发表于 Cancer Epidemiology, Biomarkers & Prevention（2024），DOI：10.1158/1055-9965.EPI-24-0144。项目资助方：Cancer Research UK (CRUK)。源站首次发布：2024-10-02。
【数据内容】
源站原始描述：Early-stage disease: likelihood (OR with 95% CI and P values from logistic regression) of receiving trastuzumab by deprivation and adjusted for age, ethnicity, rural/urban residence, government region, stage at diagnosis, whether received surgery, ER status, comorbidities, whether discussed at MDT meeting, and diagnosis year for women with stage I–III HER2+ breast cancer who were diagnosed between January 01, 2012 and December 31, 2017 (n = 34,616)
【数据结构与技术规格】
文件数 1 个，合计 22.02 KB。Table_2.xls：application/vnd.ms-excel，22.02 KB。数据集 DOI：10.1158/1055-9965.27151082。
【主题与分类】
源站学科分类：Cancer、Therapeutic Research and Development、Clinical Research and Trials、Epidemiology。主题标签：Biological Agents & Therapies、Breast Cancer、Epidemiology、Precision Medicine。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面：https://aacr.figshare.com/articles/dataset/Table_2_from_Sociodemographic_Disparities_in_HER2_sup_sup_Breast_Cancer_Trastuzumab_Receipt_An_English_Population-Based_Study/27151082
使用许可：CC BY（https://creativecommons.org/licenses/by/4.0/）。
规范引用：Norris, Ruth P.; Dew, Rosie; Greystoke, Alastair; Cresti, Nicola; Cain, Henry; Todd, Adam; et al. (2024). Table 2 from Sociodemographic Disparities in HER2+ Breast Cancer Trastuzumab Receipt: An English Population-Based Study. American Association for Cancer Research. Dataset
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载，适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档，适合快速预览和评估数据集质量。
免登录当前数据集主要来源为 Kaggle 公开托管，完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取（Figshare）
- 源站标题：Table 2 from Sociodemographic Disparities in HER2<sup>+</sup> Breast Cancer Trastuzumab Receipt: An English Population-Based Study
- DOI：10.1158/1055-9965.27151082
- 发布日期：2024-10-02
- 文件数：1 个
- 文件总体积：22.02 KB
- 源站页面：https://aacr.figshare.com/articles/dataset/Table_2_from_Sociodemographic_Disparities_in_HER2_sup_sup_Breast_Cancer_Trastuzumab_Receipt_An_English_Population-Based_Study/27151082
命令行下载
curl -L -o "Table_2.xls" "https://ndownloader.figshare.com/files/49558457"
文件清单
Table_2.xls（22.02 KB）
文件总体积 22.02 KB（源站 API 实测）。
数据说明
Early-stage disease: likelihood (OR with 95% CI and P values from logistic regression) of receiving trastuzumab by deprivation and adjusted for age, ethnicity, rural/urban residence, government region, stage at diagnosis, whether received surgery, ER status, comorbidities, whether discussed at MDT meeting, and diagnosis year for women with stage I–III HER2+ breast cancer who were diagnosed between January 01, 2012 and December 31, 2017 (n = 34,616).
许可
CC BY
引用
学术使用请引用 DOI 10.1158/1055-9965.27151082（source: https://aacr.figshare.com/articles/dataset/Table_2_from_Sociodemographic_Disparities_in_HER2_sup_sup_Breast_Cancer_Trastuzumab_Receipt_An_English_Population-Based_Study/27151082）。
需要用于商业化训练或医疗器械注册（NMPA/FDA）？
公开数据往往缺乏完整的病理回证与专家标注。千方医数集依托陕川双基地与超十家三甲医院直连，提供完全合规、去标识化、支持注册级质控的专病数据集交易服务。
